PBS
$3 billion PBS cut cause to worry: PSA
Consumers should be concerned by reports that the Commonwealth Government plans to cut $3 billion from the PBS in next month’s federal budget, says the PSA. PSA says such cuts …
De-listing of paracetamol “pure speculation” – Guild
The de-listing of some OTC medications from the PBS is “pure speculation” and a decision not to be taken lightly, says NSW Guild president, Paul Sinclair.
MA calls for better cancer drugs access
Medicines Australia and medicines industry representatives have appeared before the Senate Inquiry into the availability of new, innovative and specialist cancer drugs in Australia, calling for improvements to create an …
Call for opioid maintenance therapy copay on PBS
Ensuring Opioid Maintenance Therapy is affordable for patients is an important strategy in helping stem prescription opioid and heroin addiction, a new report has found – but the current copayment …
New HIV triple-antiviral on PBS
A new HIV medicine is now available on the PBS to add to the range of treatment options available for people living with HIV in Australia.
Huge support for new cancer medicines to go on PBS
New findings released by Newspoll show overwhelming support for access to new cancer medicines through the PBS for Australian patients. Newspoll found 97% of Australians strongly support the subsidisation of …
MA Chair welcomes industry, Govt collaboration
Medicines Australian Chairman, Dr Martin Cross has welcomed ongoing collaboration between the pharmaceutical industry and Government in addition to further improvements to the Governments post-market review program, which was announced …
Don’t fear the TPP: Medicines Australia
The Trans Pacific Partnership (TPP) Agreement will open up vast new markets for Australian companies, including manufacturers of innovative medicines and vaccines, Medicines Australia CEO, Tim James, said today. “Pharmaceuticals …
IGR shows PBS sustainable: James
The fourth Intergenerational Report reaffirms the sustainability of the PBS, says Medicines Australia. Its CEO, Tim James, welcomed the release of the 2015 report, and says it acknowledges that growth …
Patients dying in cancer drugs wait: MA
Australian cancer patients don’t have time to wait for access to new cancer drugs, says Medicines Australia. In its submission to the Senate Inquiry into the availability of new, innovative …
Govt urged to recognise PBS sustainability
Medicines Australia is calling on the Australian Government to recognise the ongoing sustainability of the PBS resulting from reforms introduced in collaboration with the industry, in its submission to the …
Price cut causes Invokana withdrawal
Janssen-Cilag has withdrawn a diabetes drug from the PBS after the Health Department requested a price cut of close to 40%
